Central airway stenting in oncology

Introduction. Malignant central airway obstruction and malignant tracheoesophageal fistula in the context of tumor development are potentially life-threatening conditions which usually require immediate intervention. Airway stenting is one of the safest and most effective methods of airway patency restoration in patients with malignant obstruction of the central airways and restoration of continuity in patients with malignant tracheoesophageal fistula.

Aim. To evaluate the significance of self-expandable metal stents in palliative treatment of patients with malignant central airway obstruction and malignant tracheoesophageal fistula.

Materials and methods. Between 2017 and 2021 at the N. N. Blokhin National Medical Research Center of Oncology, 55 patients were observed and treated and underwent trachea stenting per the results of bronchoscopy in combination with esophagogastroduodenoscopy. The 1st group included 25 patients with malignant tracheoesophageal fistulas, the 2nd group included 30 patients with malignant central airway obstruction.

Results. In the 1^st group, stenting was successful in 25 (100 %) cases which allowed to adequately seal the fistula. Stent migration was observed in 1 (4 %) patient with tracheoesophageal fistula in the context of stenosing cancer of the thoracic esophagus. In the 2^nd group, stenting was successful in 30 (100 %) cases. Stent migration was not observed in this patient group. In both groups, there were no complications after stent implantation. Installation of tracheal stent allowed to improve patients’ quality of life and provide a possibility for successful special treatment through low-trauma manipulation.

Conclusion. According to the obtained data, endoscopic trachea stenting is the most important method of palliative treatment of tumor-related trachea lesions with development of tracheoesophageal fistulas, malignant central airway obstructions and associated sub- and decompensated pulmonary insufficiency.

1. Ost D.E., Ernst A., Grosu H.B. et al. Therapeutic bronchoscopy for malignant central airway obstruction: success rates and impact on dyspnea and quality of life. Chest 2015;147(5):1282–98. DOI: 10.1378/chest.14-1526

2. Short M.W., Burgers K.G., Fry V.T. Esophageal cancer. Am Fam Physician 2017;95(1):22–8.

3. Zhou C., Hu Y., Xiao Y. et al. Current treatment of tracheoesophageal fistula. Ther Adv Respir Dis 2017;11(4): 173–80. DOI: 10.1177/1753465816687518

4. Short M.W., Burgers K.G., Fry V.T. Esophageal cancer. Am Fam Physician 2017;95(1):22–8.

5. AlTarawneh S., Obeidat Y., Sherif A. et al. A complicated parenchymal-esophageal fistula in non-small cell lung cancer. Cureus 2022;14(2):e22149. DOI: 10.7759/cureus.22149.

6. Murgu S.D., Egressy K., Laxmanan B. et al. Central airway obstruction: benign strictures, tracheobronchomalacia, and malignancy-related obstruction. Chest 2016;150(2):426–41. DOI: 10.1016/j.chest.2016.02.001

7. Oki M., Saka H. Airway stenting for patients with airway stenosis because of small cell lung cancer. Clin Respir J 2018;12(7):2257–63. DOI: 10.1111/crj.12901

8. Nagano H., Kishaba T., Nei Y. et al. Indications of airway stenting for severe central airway obstruction due to advanced cancer. PLoS One 2017;12(6):e0179795. DOI: 10.1371/journal.pone.0179795

9. Takeno A., Masuzawa T., Murakami K. et al. Tracheo-bronchial airway stenting for airway stenosis due to inoperable advanced esophageal cancers. Gan to Kagaku Ryoho 2018;45(13):2241–3.

10. Cheng W.C., Shen M.F., Wu B.R. et al. The prognostic predictors of patients with airway involvement due to advanced esophageal cancer after metallic airway stenting using flexible bronchoscopy. J Thorac Dis 2019;11(9):3929–40. DOI: 10.21037/jtd.2019.08.108